ANDROMEDA METALS LIMITED — Director's Dealing 2020

Dec 3, 2020

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11

Name of entity ANDROMEDA METALS LIMITED ABN 75 061 503 375

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Rhoderick Gordon John Grivas
Date of last notice	24 June 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Goodheart Pty Ltd (as trustee for GBH Trust)
Date of change		27 November 2020 (exercise of options) 27 and 30 November (sale of shares)
No. of securities held prior to change		Direct • Nil Indirect • 5,199,055 ordinary shares • 10,245,159 ADNOB listed options with an exercise price of $0.012 and expiry date of 30 November 2020 • 8,000,000 unlisted options with an exercise price of $0.064 and an expiry date of 28 November 2022 • 3,500,000 unlisted options with an exercise price of $0.075 and an expiry date of 28 November 2023, and which vest 12 months after the 2019 AGM as long as Mr Grivas is still a director of ADN at that time

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class		Listed options Ordinary shares
Number acquired		10,245,159 ordinary shares
Number disposed		448,602 ordinary shares 10,245,159 ADNOB listed options
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		Sale of ordinary shares @ $0.272 per share (average) Exercise of ADNOB options @ $0.012 per option
No. of securities held after change		Direct • Nil Indirect • 14,995,612 ordinary shares • 8,000,000 unlisted options with an exercise price of $0.064 and an expiry date of 28 November 2022 • 3,500,000 unlisted options with an exercise price of $0.075 and an expiry date of 28 November 2023, and which vest 12 months after the 2019 AGM as long as Mr Grivas is still a director of ADN at that time
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Sale of 448,602 ordinary shares on market to fund exercise of 10,245,159 ADNOB listed options

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3– +Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3